GoodRx Holdings jumps on upbeat forecast, Q4 results beat

GoodRx Holdings

29/02/2024 13:51

** Shares of digital healthcare platform GoodRx Holdings
 GDRX.O  rise 11.3% to $7.20 premarket
    ** Co forecasts FY24 revenue ~$800 mln; above Wall Street
view of $790.50 mln - LSEG data
    ** Sees Q1 revenue in range of $195 mln to $198 mln; higher
than analysts' estimates of $192.90 mln
    ** Q4 revenue of $196.60 mln beat market view of $195.80 mln
    ** Quarterly adj. EPS of 8 cents; compared to average
estimates of 7 cents
    ** Board approves new stock repurchase program of up to $450
mln of class A common stock
    ** Seven of 20 brokerages rate the stock "buy" or higher, 12
"hold" and one "sell"; their median PT is $7
    ** Up to Wednesday's close, stock had fallen 3.4% YTD;
compared to drop of ~44% in 2023

 (Reporting by Khushi Singh in Bengaluru)
 ((Khushi.Singh@thomsonreuters.com;))